Hansoh Pharmaceutical GroupHNSPF
13F holders, Q1 2026 (March 31)1holders
$0.12avg. 13F price*
At the end of Q1 2026, 1 institutions reported holding Hansoh Pharmaceutical Group (HNSPF) in their 13F filings. The largest holder was Ghisallo Capital Management LLC ($33.2M).
- Company
- Hansoh Pharmaceutical Group
- Filed as
- SRIAD 02/03/33 CVT PUT (Q1 2026)
- CUSIP
- G54958106
- Latest filing quarter
- Q1 2026
Total Exit/New Position Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $33.2M |
| Exits | 0 | $0 |
Ownership 1 holders
| Ghisallo Capital Management LLC | 0.92% | New | 273,000,000 | $33.2M |
"% of holder's portfolio" is HNSPF's weight in each manager's 13F, not the share of Hansoh Pharmaceutical Group the manager owns.